Expertise in
2
conditions

Dr. Paul Wylie

Sleep Medicine
Office
11219 Financial Centre Pkwy, 
Little Rock, AR 
Expertise in
2
conditions
Office
11219 Financial Centre Pkwy, 
Little Rock, AR 

Overview

Paul Wylie is a Sleep Medicine provider in Little Rock, Arkansas. Dr. Wylie is highly rated in 2 conditions, according to our data. His top areas of expertise are Central Sleep Apnea, Obstructive Sleep Apnea, Schizophrenia, and Schizoaffective Disorder.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Sleep Medicine

Licenses

Psychiatry & Neurology in AR

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
QualChoice
  • MEDICARE MAPD
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Office
11219 Financial Centre Pkwy, Little Rock, AR 72211

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
Enrollment Status: Completed
Publish Date: May 29, 2025
Intervention Type: Drug
Study Drug: BTRX-335140
Study Phase: Phase 2
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
Phase 2, Randomized, 3-Period, Placebo-Controlled Crossover Study to Evaluate the Efficacy and Safety in Obstructive Sleep Apnea of AD036 Versus Placebo or Atomoxetine
Phase 2, Randomized, 3-Period, Placebo-Controlled Crossover Study to Evaluate the Efficacy and Safety in Obstructive Sleep Apnea of AD036 Versus Placebo or Atomoxetine
Enrollment Status: Completed
Publish Date: September 14, 2023
Intervention Type: Drug
Study Phase: Phase 2
Phase 2 Randomized Double-Blind Placebo-Controlled 4-Period Single-Dose Crossover Factorial Study to Evaluate the Contribution of the Individual Drug Components to the Efficacy of AD109 in Obstructive Sleep Apnea
Phase 2 Randomized Double-Blind Placebo-Controlled 4-Period Single-Dose Crossover Factorial Study to Evaluate the Contribution of the Individual Drug Components to the Efficacy of AD109 in Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: January 31, 2023
Intervention Type: Drug, Diagnostic test
Study Drugs: AD109, Atomoxetine, R-oxybutynin
Study Phase: Phase 2
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: January 17, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder
A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Terminated
Publish Date: June 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
BIG4 - CPAP Educational Materials and Usage Feedback to Promote CPAP Adherence
BIG4 - CPAP Educational Materials and Usage Feedback to Promote CPAP Adherence
Enrollment Status: Completed
Publish Date: April 05, 2019
Intervention Type: Behavioral
Study Phase: Not Applicable
View 7 Less Clinical Trials

5 Total Publications

Effectiveness of an Intervention Providing Digitally Generated Personalized Feedback and Education on Adherence to Continuous Positive Airway Pressure: Randomized Controlled Trial.
Effectiveness of an Intervention Providing Digitally Generated Personalized Feedback and Education on Adherence to Continuous Positive Airway Pressure: Randomized Controlled Trial.
Journal: Journal of medical Internet research
Published: June 09, 2022
Similar Doctors
Expertise in
28
conditions
Dr. Keith Schluterman
Sleep Medicine
Expertise in
28
conditions
Dr. Keith Schluterman
Sleep Medicine

Office

2200 Ada Ave Ste 305, 
Conway, AR 
 (21.5 miles away)
501-932-0352
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Keith Schluterman is a Sleep Medicine provider in Conway, Arkansas. Dr. Schluterman is highly rated in 28 conditions, according to our data. His top areas of expertise are Obstructive Sleep Apnea, Essential Tremor, Lewy Body Dementia (LBD), and Seizures.

Expertise in
14
conditions
Dr. Ali Al
Sleep Medicine
Expertise in
14
conditions
Dr. Ali Al
Sleep Medicine

Advanced Sleep And Pulmonary Center PLLC

7240 Sheridan Rd Ste 101, 
White Hall, AR 
 (36.2 miles away)
870-247-6105
Languages Spoken:
English
See accepted insurances

Ali Al is a Sleep Medicine provider in White Hall, Arkansas. Dr. Al is highly rated in 14 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Lung Nodules, and Squamous Cell Lung Carcinoma.

Expertise in
1
conditions
Dr. David Anderson
Sleep Medicine
Expertise in
1
conditions
Dr. David Anderson
Sleep Medicine

Office

2525 College Ave, 
Conway, AR 
 (23.7 miles away)
501-712-1998
Languages Spoken:
English
See accepted insurances

David Anderson is a Sleep Medicine provider in Conway, Arkansas. Dr. Anderson is highly rated in 1 condition, according to our data. His top area of expertise is Obstructive Sleep Apnea.

Frequently Asked Questions about Dr. Paul Wylie

How do I make an appointment with Dr. Paul Wylie?

You can book an appointment with Dr. Paul Wylie by calling their office at 501-661-9299. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Paul Wylie a top-rated expert for Central Sleep Apnea?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Paul Wylie is classified as an Advanced expert for Central Sleep Apnea, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Paul Wylie specialize in?

While Dr. Paul Wylie is a Sleep Medicine, they have specific expertise in Central Sleep Apnea, Obstructive Sleep Apnea, and Schizophrenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Sleep Medicine.

Does Dr. Paul Wylie participate in research or clinical trials?

Yes. Dr. Paul Wylie has published 5 articles and abstracts on conditions like Central Sleep Apnea. You can view a list of Dr. Paul Wylie's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Paul Wylie accept my insurance?

Dr. Paul Wylie accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 501-661-9299 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wylie's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile